Engagement of the T cell receptor for antigen activates phospholipase C resulting in an increase in intracellular flee calcium concentration ([Ca 2+ ]i) and activation of protein kinase C (PKC). Increased [Ca2+]i activates Ca2+/calmodulin-dependent kinases including the multifunctional Ca2+/calmodulin-dependent protein kinase II (CaM-K II), as well as calcineurin, a type 2B protein phosphatase. Recent studies have identified calcineurin as a key enzyme for interleukin (IL)-2 and II:4 promoter activation. However, the role of CaM-K II remains unknown. We have used mutants of these kinases and phosphatases ('yB*CaM-K and ACaM-AI, respectively) to explore their relative role in cytokine gene transcription and their interactions with PKC-dependent signaling systems. 7B*CaM-K and ACaM-AI, known to exhibit constitutive Ca2+-independent activity, were cotransfected (alone or in combination) in Jurkat T cells with a plasmid containing the intact Ib2 promoter driving the expression of the chloramphenicol acetyltransferase reporter gene. Cotransfection of 3,B*CaM-K with the IL-2 promoter construct downregulated its transcription in response to stimulation with ionomycin and phorbol myristate acetate (PMA). The inhibitory effect of CaM-K II on I1:2 promoter was associated with decreased transcription of its AP-1 and NF-AT transactivating pathways. Under the same conditions, ACaM-AI superinduced I1:2 promoter activity (approximately twofold increase). When both mutants were used in combination, "yB*CaM-K inhibited the induction of the I1:2 promoter by ACaM-AI. Similar results were obtained when a construct containing the I1:4 promoter also was used. yB*CaM-K also downregulated the activation of AP-1 in response to transfection with a constitutively active mutant of PKC or stimulation with PMA. These results suggest that CaM-K II may exert negative influences on cytokine gene transcription in human T cells, and provide preliminary evidence for negative cross-talk with the calcineurin-and PKC-dependent signaling systems.
I
1:2 gene transcription is controlled by a promoter region extending •326 bp upstream of the transcription start site. This promoter region contains binding sites for at least five nuclear proteins including nuclear factors NF-AT, Oct-l, NF-~B, AP-1, and CD28KC (1, 2) . Both an increase of cytoplasmic calcium (Ca 2+) and activation of protein kinase C (PKC) are required for its activation in resting T cells.
Recent studies have established that the Ca2+/calmodulindependent protein kinase II (CaM kinase II) is the general or multifunctional kinase of CaZ+-signaling systems (reviewed in 3). CaM kinase II is present in most tissues as an oligomer composed of 6-12 subunits, depending on the isoform and tissue. All 11 isoforms described to date (c~, o~33, fl, B', 3'A, yB, 3'c, 8A, /iB or ~i3, /ic or/i2, 6D or 64) share a highly conserved catalytic domain at the NH2-terminal portion of the molecule, an autoinhibitory sequence overlapping with a calmodulin binding region and an association domain which is important for the formation of the holoenzyme (3) (4) (5) . After an increase in intracellular flee Ca 2+ concentration ([Ca2+]i), Ca 2 § activates CaM kinase II causing the kinase to phosphorylate itself on the Thr 286 (~ isoform) or Thr 2s7 (B and "y isoforms) site of the autoinhibitory domain. This phosphorylation event results in disruption of the autoinhibitory domain and Ca2+-independent activity (m20-80% of maximal CaZ+-stimulated activity) (3) . Mutations at Thr TM (e.g., change to Asp) result in mutants with 20-40% activity in the absence of Ca 2+/calmodulin stimulation (3). Constitutively active mutants of CaM kinase II can be used to investigate its role in the transcriptional regulation and to isolate the potential effects of this enzyme from other Ca 2+-dependent events (6) .
Increase in [Ca2+] i and activation of calmodulin may also activate Ca2+/calmodulin-dependent phosphatases such as calcineurin, a type 2B serine/threonine protein phosphatase.
Work from several laboratories has identified calcineurin as a key enzyme needed for Ib2 and II:4 promoter activity (7) (8) (9) . In addition to its effects on the intact II:2 promoter, calcineurin can separately lead to the transactivation of nuclear factors NF-AT and Oct-1 (NF-IL2A, OAP/Oct-1). More recent data have also suggested that calcineurin may act in synergy with PMA to inactivate Ir,.B/MAD3, an inhibitor of NF-gB, thereby resulting in net activation of the NF-gB (10) .
Whereas the role of CaM kinase II has been well defined in neuronal tissues, its role in T cell activation remains largely unknown. In human lymphocytes, stimulation via the TCK or with calcium ionophores increases CaM kinase II activity (5, 11) . Using constitutively active mutants of CaM kinase II, calcineurin, and PKC, we asked whether CaM kinase II is involved in the regulation of Ib2 and Ib4 promoter transcription and its influence on the effects of calcineurin-and PKC-dependent signaling systems. Our data indicate that CaM kinase downregulates the transcription of these cytokines and provides preliminary evidence for cross-talk among these pathways.
Materials and Methods
Cell Culture. Human Jurkat T cells were cultured in RPMI-1640 supplemented with 10% heat-inactivated FCS, 25 /~g/ml gentamicin, and 5 x 10 -s M 2-ME (Sigma Chemical Co., St. Louis, MO).
Plasmid Constructs. The reporter plasmid II.-2 CAT contains the human IL-2 promoter (base pairs -448 to +43) directing the transcription of the chloramphenicol acetyltransferase (CAT) gene. This plasmid also includes an SV40 polyadenylation site between vector sequences and -448 of the IL-2 promoter to prevent vector-dependent transcription from contributing to the observed CAT activity (7) . Plasmid AP-1 CAT (TRE-tk CAT) (a gift from Dr. M. Karin, University of California at San Diego, La Jolla, CA) contains a synthetic oligonucleotide from -73 to -65 of the human collagenase gene cloned into the HindlII/BamHI cut of pBLCAT 2, which contains the Herpes simplex virus thymidine kinase promoter from position -109 to + 51 in front of the CAT structural gene (12) . Plasmid NF-AT CAT (a gift from Dr. G. R. Crabtree, Stanford University, Stanford, CA) has three copies of NF-AT-binding site containing 5' 11.,2 sequences -255 to -285 linked to the IL-2 promoter sequences from -72 to +47 linked to the CAT gene (8) . Plasmid ID4 CAT (a gift from Dr. G. Thyphronitis, Institute Pasteur, Lille, France) contains the human IL-4 promoter (base pairs -418 to +50) cloned into the Not I site of pUMSPL, which is on a pSVOCAT-based vector that contains the upstream sequences of the c-mos gene to stop read-through transcription, and the polylinker of the pBluescript. Plasmid ~,B*CaM-K (a gift from Dr. H. Schulman, Stanford University, Stanford, CA) is a constitutive mutant of the human T lymphocyte 'yBCaM kinase (5) . EcoRl linkers were added to the ClaI-NotI fragment containing the full-length 3rBCaM kinase. This fragment was then inserted into pSRc~BKS, forming a complete 3~CaM kinase-SRcr expression construct. Subsequently, Thr 2s7 was replaced with Asp using site-directed mutagenesis to make mutant 3,B*CaM-K. This mutation mimics the effect of autophosphorylation on disrupting the autoinhibitory domain and generates a CaM kinase which is substantially Ca2+-independent. 3,~*CaM-K was nearly 40% active in the absence of Ca~+/calmodulin (5) . In cells stimulated with ionomycin and PMA, and transfected with 10/~g of-yB*CaM-K, the activity (determined in cytoplasmic extracts using the synthetic peptide substrate syntide that is recognized by this kinase) was twoto threefold higher than in cells transfected with its vector (data not shown). Plasmid double mutant (inactive/constitutive) 3,sCaM-K (also a gift from Dr. H. Schulman) is the catalytically inactive mutant of 3,B*CaM-K. Double mutant 3,B*CaM-K was constructed by replacing Lys 43 (which is a conserved residue essential for catalytic activity) with Met in the ATP binding (catalytic) domain. Plasmid ACaM-AI (a gift from Dr. R. L. Kincaid, Human Genome Sciences, Inc., Rockville, MD) is a deletion mutant of the catalytic subunit of the wild-type murine calcineurin, the sequence of which has 99% homology to the corresponding human subunit. ACaM-AI lacks functional CaM-binding and autoinhibitory domains. This truncation was designed to mimic proteolyzed forms of the phosphatase known to have Ca 2+-independent, constitutive phosphatase activity in vitro (7) . Plasmid APKCB (a gift from Dr. M.-A. Muramatsu, University of Tokyo, Tokyo, Japan) is the constitutively active mutant of PKCB which lacks the regulatory domain (phorbol ester binding domain). APKC/J lacks the coding region for amino acids at positions 6-159 of PKCB (13) . In control experiments, the expression vector alone was used.
DNA Transfections. Transfections ofJurkat T cells were carried
out by the DEAE-dextran method as previously described (14) . To monitor and control for transfection efficiency, cells were cotransfected with pCMV.Gal which contains the CMV-IE promoter directing transcription of the bacterial B-galactosidase (~-gal) gene (7).
CATAssay. The CAT assay was carried out as described previously (14). The CAT activity was then normalized to the ~8-gal activity.
Results

"y~*CaM.K Does Not Substitute for The Ca2+-deFendent Signaling Pathway for IL2 Promoter Transactivation.
In the Jurkat model system, ACaM-AI can substitute for the Ca 2+ signal required for 1I.-2 gene transcription (7, 8, 14) . To investigate the role of CaM kinase II in the activation of the II.-2 promoter, we cotransfected a plasmid containing the II,-2 promoter linked to the CAT gene along with plasmids ACaM-AI or "ys*CaM-K into these cells. Cells were stimulated with ionomycin and/or PMA. As shown in Fig. 1 , both ionomycin and PMA were required for IL-2 promoter activation. ACaM-AI was able to partially substitute for the Ca 2+ ionophore (~50% activity as compared to stimulation with ionomycin and PMA). Furthermore, addition of ionomycin further induced IL-2 promoter activity by approximately twofold (range 1.8-2.4) suggesting that in addition to calcineurin other Ca2+-dependent pathways are also involved in IL-2 promoter activity. The effect of calcineurin was specific since it did not affect the activity of the unrelated promoter pCMV.Gal (98.9 + 15.3% of activity of cells treated with the vector alone). As shown in the same figure, these pathways most likely do not involve CaM kinase, since in similar experiments 3,s*CaM-K not only could not substitute for ionomycin but, to the contrary, exerted a negative effect on the transactivation of IIr promoter in response to stimulation with ionomycin and PMA ( Fig. 1) (see below) . mediated by these c/s-acting elements, cells were transfected with constructs containing the intact 11,2 promoter or its AP-1 and NF-AT sites linked to the CAT reporter gene. "yB*CaM-K decreased the activity of all three constructs (Fig. 2) . In four different experiments "),B*CaM-K decreased the activity of the I1,2 promoter construct by ,v50% (53.4 +_ 9.2), of the AP-1 by ,v70% (68.5 +_ 3.9), and NF-AT by ~35% (34.2 +_ 7.4). The downregulatory effect of ~/B*CaM-K was specific since it did not affect the activity of the unrelated promoter pCMV.Gal (15) . Recent data have suggested that calcineurin alone may upregulate the transcriptional activity of I1,4 (reference 9 and Paliogianni, F., N. Hama, G. J. Mavrothalassitis, G. Thyphronitis, and D. T. Boumpas, manuscript in preparation). To determine the effects of 3'B*CaM-K on this promoter, Jurkat cells were transfected with a construct of II.-4 promoter linked to the CAT reporter gene. Similar to Ib2, transfection with 3,B*CaM-K resulted in a small (•40%) but reproducible inhibition of the transcriptional activity of the I1,4 promoter in response to ionomycin or ACaM-AI (Fig. 3) . These data suggest that 3'B* CaM-K may counteract the effects of calcineurin (and probably other Ca2+-pathways).
")'B*CaM-K Counteracts the Effects of ACaM-AI on 11-,2 Promotet.
To further explore the interaction between calcineurin and CaM kinase, we cotransfected Jurkat cells with the IL-2 promoter and ACaM-AI alone or in combinatidn with 3,B*CaM-K. In cells stimulated with ionomycin and PMA cotransfection with 3,B*CaM-K completely abolished the superinduction of I1.-2 promoter in the presence of ACaM-AI (Fig. 4) . Similar to its effects on the II_,2 promoter, yB*CaM-K partially downregulated the increase in the activity of the NF-AT construct in response to stimulation with ionomycin and PMA alone or in combination with ACaM-AI (not shown). These results provide further evidence that ~/B*CaM-K may counteract the effects of calcineurin dependent-pathways on T cell activation.
"yB*CaM-K Downregulates the Effects of PKC on Transactiration of AP-1. In contrast to NF-AT whereby Ca 2+ is essential for its activation, stimulation with phorbol esters alone is sufficient and more potent than ionomycin to induce AP-1 activity (16, 17) . To explore the interaction of CaM kinase 
Discussion
In this study we have presented evidence that CaM kinase II may downregulate Ca 2+-and PKC-dependent transactivating pathways for cytokine gene transcription in human T cells. The effect of CaM kinase II seems to be spedfic since CaM kinase II does not affect the activity of the unrelated promoter pCMV.Gal. Furthermore, the double mutant (inactive/constitutive) 3,BCaM-K does not affect the IL-2 promoter activity, suggesting that inhibition of gene transcription requires the presence of a catalytically active domain of CaM kinase II and it is not due to the competing effects of the vectors used in these experiments. These results provide a molecular basis for the previously reported negative effects of the Ca2+-pathway on T cells, such as negative selection and anergy (18) (19) (20) .
IL-2 is one of the major growth factors for the cells of the immune system. Inadequate production of 1L-2 has significant consequences for the T cells and may result in anergy and tolerance. Exogenous IL-2 or costimulation via the CD28 pathway may reverse these states suggesting that the total amount of IL-2 produced in an immune response plays a critical role in determining the extent of the anergy (20, 21) . In addition to playing a major role in the physiological immune responses against foreign antigens IL-2 may also be involved in autoimmune phenomena. A stringent control of the production of Ib2 is therefore required to avoid excess production which may lead to breaking of tolerance and autoimmune phenomena.
Work from several laboratories has associated the lack of IL-2 production in anergic states to defects in the transactivation of nuclear factors, AP-1 (22), NF-AT, and NF-KB (23). These results suggest that activation of CaM kinase II may provide an additional regulatory mechanism for the fine tuning of IL-2 production during T cell activation. It is possible that the downregulation of these transactivating pathways may be due, at least in part, to activation of CaM kinase II. Although in these experiments CaM kinase II only partially inhibited IL-2 transcription, this may be su~cient to result in autocrine rather than paracrine levels of Ib2 production (20) . Furthermore, the degree of inhibition may differ among different types or clones of T cells.
In the murine system of T cell anergy, costimulation of T cells through the CD28 pathway augments Ib2 production from autocrine to paracrine levels and prevents induction of anergy (21) . Although increases in [Ca~']i during activation through TCR will activate both caldneurin (which augments IL2 production) and CaM kinase II (which decreases it), it is conceivable that additional accessory stimuli (e.g., stimulation via CD2, CD5, or CD28) may shift the balance towards one or the other of these enzymes.
Downregulation of IL-4 production of CaM kinase II is also of interest. II,-4 is the other major T cell growth factor and is essential for the regulation of humoral immune responses. Anergic T cells lose their responsiveness to II,-4 (20) . Decreased production of II.-4 by CaM kinase II may be an additional proximal mechanism to prevent proliferative response by these cells.
This study has presented preliminary data on cross-talk between the CaM kinase II and calcineurin signaling systems. During T cell activation the partial inhibition of IL-2 or II,-4 promoter activity by CaM kinase II suggests that their effects may be exerted at more distal sites in the calcineurin regulated pathways. Calcineurin is known to activate several discrete transactivating pathways including NF-AT, Oct-1/OAP, and NF-KB and to downregulate the activity of AP-1 (7-10). Hashimoto et al. (24) have shown that calcineurin is phosphorylated by the autophosphorylated form of CaM kinase II. Whether these in vitro data have any relevance to explaining the attenuating effects of CaM kinase II on calcinenrin in vivo can not be addressed by these studies.
Whereas it is well established that PKC may exhibit both negative and positive cross-talk with CaM kinase II (25) , the effects of CaM kinase on PKC are less well characterized. Our data provide for the first time evidence that CaM kinase II may downregulate PKC-dependent pathways for T cell activation. Once more the partial inactivation of the PKC mediated AP-1 induction suggests that CaM kinase II more likely affects distal sites in the PKC mediated pathway.
In summary, our data have identified CaM kinase II as a potential candidate for some of the negative effects of the CF+-pathway on T cell activation. Furthermore, these data provide indirect evidence for cross-talk between the calcium and the PKC pathways during T call activation. Additional studies should further ddineate this interaction and determine its importance for the activation of T cells.
